文献速递腹部CT

低 keV 门静脉期替代胰腺期:双能 CT 胰腺方案可行性研究

Low keV portal venous phase as a surrogate for pancreatic phase in a pancreatic protocol dual-energy CT: feasibility, image quality, and lesion conspicuity.
PubMed 文献 · Eur Radiol · 2021-03-20

本研究纳入 111 例接受胰腺方案双能 CT(胰腺期 PP 与门静脉期 PVP)的患者,比较标准方案(50 keV PP/65 keV PVP)与拟议方案(40 keV/65 keV PVP)的图像质量、病灶显示及动脉受累评估。结果显示两方案图像质量、胰腺 SNR 及病灶-胰腺 CNR 相当,胰腺导管腺癌和胰腺囊肿的病灶显示相当,大动脉显示及动脉受累评估相当,但标准方案对小血管的评分更高;拟议方案 DLP 为 670.4 mGy·cm,较标准方案 1145.9 mGy·cm 预计降低 42%。

要点

  • 单次 PVP 双能 CT 采集生成的 40 keV/65 keV 胰腺方案与标准双期方案图像质量及病灶显示相当。
  • 拟议方案 DLP 670.4 mGy·cm,较标准方案 1145.9 mGy·cm 预计降低 42%。
  • 标准方案对小血管的显示评分高于拟议方案,评估小血管受累时需注意。

关键影像表现/征象

  • 标准方案与拟议方案的图像质量、胰腺 SNR 及病灶-胰腺 CNR 相当(p = 0.11–1.00)。
  • 胰腺导管腺癌(p = 0.55)和胰腺囊肿(p = 0.28)的病灶显示在两方案间相当。
  • 大动脉显示及动脉受累评估在两方案间相当(p = 0.056–1.00),但标准方案对小血管的评分更高(p < 0.0001–0.0015)。

诊断标准与关键数值

  • 图像质量、病灶显示及动脉显示/受累均采用 5 分法评估。
  • 拟议方案 DLP 670.4 mGy·cm,标准方案 DLP 1145.9 mGy·cm,拟议方案预计降低 42%(p < 0.0001)。

临床应用与阅片要点

  • 拟议方案可用于评估胰腺局灶性病变及大动脉受累,图像质量与标准双期方案相当。
  • 评估小血管时标准方案评分更高,拟议方案在小血管显示方面可能不足。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To assess the feasibility of a proposed pancreatic protocol CT generated from portal-venous phase (PVP) dual-energy CT (DECT) acquisition and its impact on image quality, lesion conspicuity, and arterial visualization/involvement.

METHODS: We included 111 patients (mean age, 66.8 years) who underwent pancreatic protocol DECT (pancreatic phase, PP, and PVP). The original DECT acquisition was used to create two data sets-standard protocol (50 keV PP/65 keV PVP) and proposed protocol (40 keV/65 keV PVP). Three reviewers evaluated the two data sets for image quality, lesion conspicuity, and arterial visualization/involvement using a 5-point scale. The signal-to-noise ratio (SNR) of pancreas and lesion-to-pancreas contrast-to-noise ratio (CNR) was calculated. Qualitative scores, quantitative parameters, and dose-length product (DLP) were compared between standard and proposed protocols.

RESULTS: The image quality, SNR of pancreas, and lesion-to-pancreas CNR of the standard and proposed protocol were comparable (p = 0.11-1.00). Lesion conspicuity was comparable between the standard and proposed protocols for pancreatic ductal adenocarcinoma (p = 0.55) and pancreatic cysts (p = 0.28). The visualization of larger arteries and arterial involvement were comparable between the two protocols (p = 0.056-1.00) while the scores were higher for smaller vessels in the standard protocol (p < 0.0001-0.0015). DLP of the proposed protocol (670.4 mGy·cm) showed a projected 42% reduction than the standard protocol (1145.9 mGy·cm) (p < 0.0001).

CONCLUSION: Pancreatic protocol CT generated from a single PVP DECT acquisition is feasible and could potentially be an alternative to the standard pancreatic protocol with PP and PVP.

KEY POINTS: • The lesion conspicuity for focal pancreatic lesions was comparable between the proposed protocol and standard dual-phase pancreatic protocol CT. • Qualitative and quantitative image assessments were almost comparable between two protocols. • The radiation dose of a proposed protocol showed a projected 42% reduction from the conventional protocol.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Noda Y, Tochigi T, Parakh A, et al. Low keV portal venous phase as a surrogate for pancreatic phase in a pancreatic protocol dual-energy CT: feasibility, image quality, and lesion conspicuity. Eur Radiol. 2021. PMID: 33744992. doi:10.1007/s00330-021-07744-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。